{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:46:35Z","timestamp":1789447595209,"version":"build-2803163510"},"reference-count":66,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2011,11,29]],"date-time":"2011-11-29T00:00:00Z","timestamp":1322524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Prostate"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Prostate cancer is the most common malignancy in men in the Western world and represents a major health problem with substantial morbidity and mortality. Sensitivity and specificity of digital rectal examination (DRE) and evaluation of prostate specific antigen (PSA) are excellent methods for diagnosis of prostate cancer, but have limited value for staging. Imaging of prostate cancer has become increasingly important to improve staging and management of prostate cancer patients. Conventional imaging modalities, such as transrectal ultrasound and computed tomography, show limited accuracy for a reliable assessment of prostate cancer. Diagnostic value of magnetic resonance imaging has improved by dynamic contrast enhancement (DCI\u2010MRI) and diffusion\u2010weighted magnetic resonance imaging (DWI). Recently, substantial progress has been made in the development of functional and molecular imaging modalities, such as positron emission tomography using radiolabeled metabolic tracers, receptor\u2010binding ligands, amino acids, peptides, or antibodies. Here, we review the value of these novel radionuclide imaging techniques in the assessment of prostate cancer. Prostate 72:1262\u20131272, 2012. \u00a9 2011 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/pros.22462","type":"journal-article","created":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T07:57:07Z","timestamp":1322726227000},"page":"1262-1272","source":"Crossref","is-referenced-by-count":25,"title":["Prospects in radionuclide imaging of prostate cancer"],"prefix":"10.1002","volume":"72","author":[{"given":"Susanne","family":"L\u00fctje","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto C.","family":"Boerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina M.","family":"van Rij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Sedelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wijnand","family":"Helfrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim J.G.","family":"Oyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.A.","family":"Mulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,11,29]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.12.014"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp900069d"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.2527"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-010-0102-z"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70103-0"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2431030580"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.175.4.1751161"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2009.27"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-008-0968-z"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2005.02.001"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)00920-8"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2452062201"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-007-9181-9"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.06.1329"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70203-1"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200309043491026"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-009-9681-3"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160809"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2005.09.001"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)00896-7"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1613-z"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2010.08.005"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-004-1741-4"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2004.03.051"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0302-2838(02)00129-X"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2007.07083.x"},{"issue":"5","key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1160\/nukmed-0075","article-title":"Comparison of 11C\u2010choline\u2010PET\/CT and whole body\u2010MRI for staging of prostate cancer","volume":"46","author":"Eschmann SM","year":"2007","journal-title":"Nuklearmedizin"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.050658"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0163-x"},{"issue":"4","key":"e_1_2_6_31_2","first-page":"549","article-title":"11C\u2010acetate PET imaging of prostate cancer: Detection of recurrent disease at PSA relapse","volume":"44","author":"Oyama N","year":"2003","journal-title":"J Nucl Med"},{"issue":"3","key":"e_1_2_6_32_2","first-page":"420","article-title":"18F\u2010fluoroactetate: A potential acetate analog for prostate tumor imaging\u2014In vivo evaluation of 18F\u2010fluoroactetate versus 11C\u2010acetate","volume":"48","author":"Ponde DE","year":"2007","journal-title":"J Nucl Med"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1437-1"},{"issue":"2","key":"e_1_2_6_34_2","first-page":"287","article-title":"The detection of bone metastases in patients with high\u2010risk prostate cancer: 99mTc\u2010MDP planar bone scintigraphy, single\u2010 and multi\u2010field\u2010of\u2010view SPECT, 18F\u2010fluoride PET, and 18F\u2010fluoride PET\/CT","volume":"47","author":"Even\u2010Sapir E","year":"2006","journal-title":"J Nucl Med"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2004.11.005"},{"issue":"2","key":"e_1_2_6_36_2","first-page":"272","article-title":"Assessment of malignant skeletal disease: Initial experience with 18F\u2010fluoride PET\/CT and comparison between 18F\u2010fluoride PET and 18F\u2010fluoride PET\/CT","volume":"45","author":"Even\u2010Sapir E","year":"2004","journal-title":"J Nucl Med"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0788-z"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.064212"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-005-1764-5"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1021\/bc034018l"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1388-2"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2010.04.016"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1261-7"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1089\/108497804773391711"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.neo.7900224"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020070"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.048009"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.061739"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpuro0452"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.183.2.1830519"},{"issue":"18","key":"e_1_2_6_51_2","first-page":"4055","article-title":"Constitutive and antibody\u2010induced internalization of prostate\u2010specific membrane antigen","volume":"58","author":"Liu H","year":"1998","journal-title":"Cancer Res"},{"issue":"4","key":"e_1_2_6_52_2","first-page":"610","article-title":"Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate\u2010specific membrane antigen: Preclinical studies in nude mice bearing LNCaP human prostate tumor","volume":"44","author":"Smith\u2010Jones PM","year":"2003","journal-title":"J Nucl Med"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.21176"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000091655.77601.0c"},{"issue":"15","key":"e_1_2_6_55_2","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1200\/jco.2008.26.15_suppl.5140","article-title":"Phase II trial of 177Lutetium radiolabeled anti\u2010prostate\u2010specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu\u2010J591) in patients with metastatic castrate\u2010resistent prostate cancer","volume":"26","author":"Tagawa ST","year":"2008","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.21090"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203426"},{"issue":"2","key":"e_1_2_6_58_2","first-page":"501","article-title":"Pretargeted immunoPET imaging and radioimmunotherapy (RIT) of prostate cancer with an anti\u2010EGP1 x anti\u2010HSG bispecific antibody (bsMAb)","volume":"51","author":"van Rij C","year":"2010","journal-title":"J Nucl Med"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1842"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e318031b53b"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-5093"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.069492"},{"issue":"1","key":"e_1_2_6_63_2","first-page":"46","article-title":"Combined 18F\u2010FDG and 11C\u2010methionine PET scans in patients with newly progressive metastatic prostate cancer","volume":"43","author":"Nu\u00f1ez R","year":"2002","journal-title":"J Nucl Med"},{"issue":"1","key":"e_1_2_6_64_2","first-page":"56","article-title":"Initial experience with the radiotracer anti\u20101\u2010amino\u20103\u201018F\u2010fluorocyclobutane\u20101\u2010carboxylic acid with PET\/CT in prostate carcinoma","volume":"48","author":"Schuster DM","year":"2007","journal-title":"J Nucl Med"},{"key":"e_1_2_6_65_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-009-0394-9"},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2690"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1517"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.22462","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pros.22462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T21:18:18Z","timestamp":1697663898000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.22462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,29]]},"references-count":66,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1002\/pros.22462"],"URL":"https:\/\/doi.org\/10.1002\/pros.22462","archive":["Portico"],"relation":{},"ISSN":["0270-4137","1097-0045"],"issn-type":[{"value":"0270-4137","type":"print"},{"value":"1097-0045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,29]]}}}